|Bid||245.15 x 10000|
|Ask||245.35 x 3400|
|Day's range||244.87 - 248.00|
|52-week range||184.62 - 253.36|
|Beta (5Y monthly)||0.45|
|PE ratio (TTM)||61.44|
|Forward dividend & yield||3.10 (1.27%)|
|Ex-dividend date||21 Mar 2023|
|1y target est||N/A|
According to the World Health Organization (WHO), the number of people living with hearing loss is set to reach 2.5 billion by 2050.1 Now, leading technology companies, researchers, and people living with hearing loss are coming together to tackle its rising impact.
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the winners of the 21st annual Graeme Clark, the 12th annual Anders Tjellström, and 1st annual Vocational Scholarships. The Academic Scholarships are named after two pioneers of the hearing implant industry and recognize Cochlear™ Nucleus® Implant, Cochlear Baha® System and Cochlear Osia® System recipients in the United States and Canada who uphold the Cochlear ideals of leadership, humanity, and dem
Ahead of International Cochlear Implant Day (February 25, 2023), Cochlear is announcing that it will now offer Audio Streaming for Hearing Aids (ASHA) support on compatible Fire TV devices for people living with hearing implant technology. The advancement represents the first time that a smart TV device will stream sound directly to a hearing implant sound processor.
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, receives U.S. Food and Drug Administration (FDA) approval for the Cochlear™ Nucleus® 8 Sound Processor. The Nucleus 8 Sound Processor is now the smallest and lightest behind-the-ear cochlear implant sound processor available in the industry. 1-3 It is also the world's first cochlear implant sound processor ready to provide direct audio connectivity to everyday consumer electronics using the next generation LE Audio